Analytical Data
-
Gene name
SPTbN4
- Application
-
Alternative Names
SPTbN4；KIAA1642；SPTBN3；Spectrin beta chain. non-erythrocytic 4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NRC6
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SPTbN4 protein, a recombinant form derived from the SPTb protein family, has garnered attention in biomedical research due to its pivotal role in various cellular processes. This protein is implicated in important functions such as signal transduction, cell differentiation, and apoptosis, making it a critical subject of study in cancer biology and developmental research. Recent studies indicate that misregulation of SPTbN4 may contribute to oncogenesis, highlighting the importance of understanding its structural and functional properties. Researchers have employed techniques like recombinant DNA technology and advanced purification methods to produce sufficient quantities of SPTbN4 for biochemical characterization. This includes analyzing its interactions with other cellular components and identifying potential post-translational modifications. Moreover, its involvement in pathways linked to key cellular functions has led to investigations about its potential as a therapeutic target. The insights gained from studying SPTbN4 not only enhance our understanding of its biochemical pathways but also pave the way for innovative strategies in drug development aimed at diseases involving dysregulated cell signaling. Thus, the research on SPTbN4 is of significant importance in elucidating the molecular mechanisms underlying various pathologies and could ultimately contribute to the advancement of targeted therapies in clinical settings. Overall, the exploration of SPTbN4 as a recombinant protein serves as a crucial framework for understanding its biological functions and potential applications in medicine.
